ICON’s ICLR focus on Patient Access & Engagement strategy is a major tailwind along with partnerships and acquisitions. The stock carries a Zacks Rank #2 (Buy) currently. ICON is gaining from its ...

Forbes contributors publish independent expert analyses and insights. Dr. Tracy Brower writes about joy, community and the future of work. Hybrid and remote work are effective for plenty of tasks—but ...

ICON Aircraft said it has incorporated performance-enhancing upgrades into the 2024 ICON A5 amphibious light sport aircraft (LSA) that shorten its takeoff distance and boost useful load. The ...

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation (CRO), finishes the second half of 2023 with positive recognition as a ...